Brief: Solid Biosciences Inc - Company Ends 2022 With Approximately $213.7 Million In Cash And Investments Anticipated Cash Runway Into 2025

Solid Biosciences

23/03/2023 13:13

March 23 (Reuters) - Solid Biosciences Inc  SLDB.O :
    * SOLID BIOSCIENCES INC - COMPANY ENDS 2022 WITH
APPROXIMATELY
$213.7 MILLION IN CASH AND INVESTMENTS; ANTICIPATED CASH RUNWAY
INTO 2025
    * SOLID BIOSCIENCES INC - REMAINS ON TRACK TO SUBMIT IND FOR
SGT
003, A NEXT-GENERATION GENE THERAPY FOR PATIENTS WITH DUCHENNE
    * SOLID BIOSCIENCES INC - NET LOSS FOR Q4 OF 2022 WAS $15.2
MILLION, COMPARED TO $18.6 MILLION FOR Q4 OF 2021

Source text for Eikon:  ID:nGNX4ZW3X1 
Further company coverage:  SLDB.O 

 ((Reuters.Briefs@thomsonreuters.com;;))